Corbus Pharmaceuticals Initiates Phase 1 Study of CRB-913 for Obesity Treatment
Corbus Pharmaceuticals has initiated the multiple ascending dose (MAD) portion of its Phase 1 trial for CRB-913, an obesity...
Assembly Biosciences Doses First Participant in Phase 1b Trial of Herpes Simplex Virus Inhibitor
Assembly Biosciences has dosed the first participant in a Phase 1b study of ABI-1179, an oral, long-acting herpes simplex...
Magic Catheter Study’s First Clinical Results Published
Stereotaxis announced the publication of initial clinical results for its MAGiC robotic magnetic navigation ablation catheter in the Journal...
Leronlimab Shows Encouraging Survival Data in Metastatic Colorectal Cancer Patients
CytoDyn announced encouraging clinical findings from a compassionate use study of leronlimab in patients with advanced metastatic colorectal cancer...
Zervimesine Alzheimer’s Study Surpasses 50% Enrollment
Cognition Therapeutics announced that its Phase 2 START Study for Alzheimer’s disease has surpassed 50% enrollment. The study, conducted...
BioXcel Therapeutics Gets Positive Recommendation for Serenity Trial
BioXcel Therapeutics’ independent Data Safety Monitoring Board (DSMB) recommended the continuation of the SERENITY At-Home Phase 3 safety trial...
Positive Phase 2B Results for Treatment-Resistant Depression
Atai Life Sciences and Beckley Psytech announced positive topline results from a Phase 2b trial of BPL-003 (intranasal mebufotenin)...
UK MHRA Approves First-in-Human Trial of RinCell-1 for Hearing Loss
Rinri Therapeutics received approval from the UK MHRA to begin its first-in-human clinical trial for Rincell-1, a regenerative cell...
ReproNovo’s RPN-001 Enters US Phase 2 Trial for Male Infertility
ReproNovo has initiated a Phase 2 clinical trial for RPN-001 (leflutrozole), an oral aromatase inhibitor designed to treat male...
Invivyd & SPEAR Study Group Launch Long COVID Monoclonal Antibody Therapy Research
Invivyd formed the SPEAR Study Group to investigate the potential of monoclonal antibody therapy for Long COVID and Post-Vaccination...